Avidity Biosciences (RNA) Enterprise Value (2019 - 2025)
Historic Enterprise Value for Avidity Biosciences (RNA) over the last 7 years, with Q3 2025 value amounting to -$1.9 billion.
- Avidity Biosciences' Enterprise Value fell 1808.42% to -$1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 billion, marking a year-over-year decrease of 1808.42%. This contributed to the annual value of -$1.5 billion for FY2024, which is 15220.37% down from last year.
- As of Q3 2025, Avidity Biosciences' Enterprise Value stood at -$1.9 billion, which was down 1808.42% from -$1.2 billion recorded in Q2 2025.
- Over the past 5 years, Avidity Biosciences' Enterprise Value peaked at -$279.5 million during Q2 2021, and registered a low of -$1.9 billion during Q3 2025.
- Moreover, its 5-year median value for Enterprise Value was -$586.3 million (2023), whereas its average is -$803.3 million.
- Its Enterprise Value has fluctuated over the past 5 years, first surged by 2070.9% in 2021, then tumbled by 19278.34% in 2024.
- Quarter analysis of 5 years shows Avidity Biosciences' Enterprise Value stood at -$405.5 million in 2021, then plummeted by 50.59% to -$610.7 million in 2022, then grew by 2.52% to -$595.4 million in 2023, then tumbled by 152.2% to -$1.5 billion in 2024, then dropped by 24.93% to -$1.9 billion in 2025.
- Its Enterprise Value was -$1.9 billion in Q3 2025, compared to -$1.2 billion in Q2 2025 and -$1.4 billion in Q1 2025.